Carrick Therapeutics Limited

Privately held: no public share price

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 1 of 1 assets
Target & Modality
Phase 2
CDK7Small molecule
Breast Cancer
HR+/HER2- Metastatic Breast Cancer

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

10 December 2025Topline resultSamuraciclibRandomised Phase 2 SUMIT-BC results presented at SABCS 2025
Carrick Therapeutics Limited · Source ↗

Financial reports

No financial reports recorded.